Lidocaine toxicity, formally called local anesthetic systemic toxicity (LAST), happens when lidocaine reaches high enough levels in the bloodstream to interfere with critical functions in the brain and heart. The condition ranges from mild symptoms like ringing ears and a metallic taste to life-threatening seizures and cardiac arrest. While lidocaine is one of the most commonly used local anesthetics in the world, the gap between a therapeutic dose and a dangerous one is narrower than many people realize, and certain patients and certain routes of exposure shrink that gap further.
How Lidocaine Works and Why Excess Is Dangerous
Lidocaine does its job by blocking sodium channels in nerve cells. Sodium channels are the gates that allow electrical signals to fire along a nerve fiber. When lidocaine plugs into those channels, the nerve can no longer transmit pain signals, which is why the area goes numb. Research on the molecular mechanism shows that lidocaine binds weakly to resting sodium channels but binds much more tightly when the channel is in its inactivated state, which is why repeated nerve firing increases the drug’s blocking effect.1PubMed. On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain This property, called “use dependence,” means the drug preferentially quiets the most active nerves.2PubMed Central. Lidocaine block of cardiac sodium channels
The problem is that sodium channels are not unique to sensory nerves. The brain and heart rely on the same type of channel to function. When lidocaine spills into the general circulation and reaches high plasma concentrations, it starts blocking sodium channels in neurons throughout the central nervous system and in cardiac muscle cells. Brain tissue is more sensitive, so neurological symptoms almost always appear before cardiovascular ones. But when blood levels climb high enough to affect the heart, the consequences can be sudden and severe, including abnormal heart rhythms, cardiovascular collapse, and cardiac arrest.3PubMed Central. Cardiac toxicity after intraurethral instillation of lidocaine: A case report and review of literature
What Causes Lidocaine to Reach Toxic Levels
Lidocaine toxicity does not require a dramatic error. It can result from any situation where more of the drug enters the bloodstream than the body can clear. The most common scenarios include:
- Excessive dose: Injecting or applying more lidocaine than the patient’s weight-based maximum allows. This is especially relevant when multiple injection sites are used in a single procedure.
- Accidental intravascular injection: If the needle tip is inside a blood vessel rather than in tissue, the full dose enters the bloodstream immediately instead of being absorbed slowly over minutes.
- Rapid absorption from mucosal surfaces: Mucous membranes in the mouth, throat, and urethra absorb lidocaine faster than intact skin. A case report documented severe cardiovascular collapse and cardiac arrest following intraurethral lidocaine instillation, highlighting how mucosal absorption can produce dangerously high blood levels.3PubMed Central. Cardiac toxicity after intraurethral instillation of lidocaine: A case report and review of literature
- Impaired metabolism: Lidocaine is broken down primarily by a liver enzyme called CYP1A2. Any condition or medication that reduces the activity of that enzyme, or that decreases blood flow to the liver, slows clearance and lets the drug accumulate.4PubMed. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function
Epinephrine is sometimes mixed with lidocaine to constrict local blood vessels, which slows absorption and prolongs the anesthetic effect. This co-formulation acts as a built-in safety measure in many procedures. However, it does not eliminate risk entirely, and in certain anatomical locations it introduces its own concerns about blood supply.5International Journal of Medical Science and Clinical Research Studies. Comparing Efficacy and Safety Aspects of 2% Lidocaine Hydrochloride Combination with 1:80.000 Added Epinephrine Solution versus the Most Commonly Used 2% Lidocaine Hydrochloride Solution in Surgical Procedures on Human Fingers and Toes
Who Is at Higher Risk
Most healthy adults tolerate lidocaine well when standard dosing guidelines are followed. But several groups face an outsized risk of toxicity, sometimes at doses that would be perfectly safe for other patients.
People with liver disease are among the most vulnerable. Lidocaine undergoes extensive first-pass metabolism in the liver, meaning a large fraction of an oral or absorbed dose is broken down before it ever reaches the systemic circulation. When liver function is compromised, that clearance drops and plasma levels can climb to dangerous concentrations even from doses that look modest on paper. A case report described central nervous system symptoms in a patient with chronic liver disease who received oral lidocaine at a dose that would ordinarily be considered safe, underscoring the need for reduced dosing in this group.6PubMed Central. Even ‘safe’ medications need to be administered with care
Drug interactions pose a related hazard. Fluvoxamine, an antidepressant, is a potent inhibitor of CYP1A2 and substantially slows lidocaine clearance. Other medications that inhibit this enzyme pathway can do the same, so a patient’s full medication list matters when determining a safe lidocaine dose.4PubMed. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function
Young children deserve special caution. Their smaller body mass means a given volume of lidocaine produces a proportionally larger blood concentration. Amide-type anesthetics like lidocaine can cause serious toxicity in young children with doses as low as one teaspoon. The effects in children tend to involve altered mental status, confusion, agitation, and seizures, with cardiovascular symptoms appearing at higher concentrations.7The Journal of Emergency Medicine. Are One or Two Dangerous? Lidocaine and Topical Anesthetic Exposures in Children This is particularly relevant in households where topical lidocaine products, such as teething gels or numbing creams, might be accessible to small hands.
Signs and Symptoms, and How They Progress
Lidocaine toxicity follows a fairly predictable escalation pattern, which is part of what makes early recognition so important. The brain reacts first, and the heart follows if levels keep rising.
Early warning signs are often subtle. Roughly one in five people experiencing LAST will notice prodromal symptoms: numbness around the mouth, a metallic taste, drowsiness, ringing in the ears, or general confusion.8PubMed Central. Seizure following in-office lidocaine administration: a case report on local anesthetic systemic toxicity These are the body’s early alarms. If the patient or clinician catches them, stopping the injection and monitoring closely can prevent progression.
When central nervous system toxicity advances, the symptoms intensify. Agitation, visual disturbances, muscle twitching, and eventually seizures can develop. Loss of consciousness is possible. In children, depressed mental status and ataxia (unsteady movement) are prominent early signs.7The Journal of Emergency Medicine. Are One or Two Dangerous? Lidocaine and Topical Anesthetic Exposures in Children
Cardiovascular toxicity appears at higher plasma levels. It can manifest as low blood pressure, a slow heart rate, conduction abnormalities on an ECG, dangerous ventricular arrhythmias, and in the worst cases, cardiac arrest. The cardiac symptoms are less common than the neurological ones but are responsible for the most catastrophic outcomes.3PubMed Central. Cardiac toxicity after intraurethral instillation of lidocaine: A case report and review of literature
There is a misconception that if nothing happens in the first few minutes after a lidocaine injection, you are in the clear. Most cases of LAST do develop within the first five minutes. But delayed onset is well documented. One case report described an 18-year-old who had seizures 210 minutes after receiving an ultrasound-guided nerve block with 30 mL of local anesthetic, well after what most clinicians would consider the window of risk.9PubMed Central. A Case of Late-Onset Local Anesthetic Toxicity Observed as Seizure Activity This can occur when the drug is deposited near a nerve sheath and absorbed slowly into surrounding tissue, creating a delayed peak in blood concentration. Monitoring for a reasonable period after regional anesthesia is not just protocol; the delayed-onset cases show why it matters.
Emergency Management
When lidocaine toxicity is recognized, the immediate priorities are straightforward: stop giving the drug, secure the airway, deliver high-concentration oxygen, and ensure intravenous access.10Revista Portuguesa de Cardiologia. Lidocaine-induced central nervous system toxicity during implantable cardioverter defibrillator placement – A case report and literature review Seizures are treated with a benzodiazepine such as diazepam or midazolam, or with small incremental doses of propofol.
If toxicity progresses to cardiac arrest, standard resuscitation protocols apply but with key modifications. Epinephrine remains the recommended drug, but the doses are much smaller than in a typical cardiac arrest. Rather than the standard 1 mg bolus used in advanced cardiac life support, clinicians are advised to start with doses between 10 and 100 micrograms, because the heart is already electrically unstable and large doses of epinephrine could worsen arrhythmias. Vasopressin, sometimes used in other cardiac arrest scenarios, has shown poor outcomes in animal models of LAST and is not recommended. Drugs that further slow electrical conduction through the heart are avoided entirely, and this list includes lidocaine itself, beta blockers, calcium channel blockers, and amiodarone.11PubMed Central. Local Anesthetic Systemic Toxicity Induced Cardiac Arrest After Topicalization for Transesophageal Echocardiography and Subsequent Treatment with Extracorporeal Cardiopulmonary Resuscitation The irony of lidocaine being on its own “do not give” list during a lidocaine toxicity event is worth noting: because the problem is sodium-channel blockade, giving more of the same class of drug would only deepen the crisis.
Lipid Emulsion Therapy
The single biggest advance in treating severe LAST over the past two decades has been intravenous lipid emulsion, commonly known by the brand name Intralipid. This fat-based solution, originally developed for intravenous nutrition, was found to reverse local anesthetic toxicity in animal models and has since been used successfully in human cases.
The leading explanation is the “lipid sink” theory: lidocaine and other local anesthetics are fat-soluble, so introducing a large volume of lipid into the bloodstream creates an alternative compartment for the drug to dissolve into, pulling it away from sodium channels in the heart and brain. Research suggests several additional mechanisms may contribute, including enhanced redistribution of the drug, direct energy supply to struggling heart muscle via fatty acids, and reversal of the sodium channel blockade itself.12PubMed Central. Lipid Emulsion for Treating Local Anesthetic Systemic Toxicity
Guidelines now recommend that any facility performing regional anesthesia or using large volumes of local anesthetic should have lipid emulsion immediately available. The treatment is typically administered as a bolus followed by a continuous infusion, and it can be started alongside other resuscitation efforts. It is not a replacement for airway management and circulatory support but an important addition to them. For refractory cases where neither lipid emulsion nor standard resuscitation restores circulation, extracorporeal cardiopulmonary resuscitation (essentially putting the patient on a heart-lung bypass machine) has been used as a last resort.11PubMed Central. Local Anesthetic Systemic Toxicity Induced Cardiac Arrest After Topicalization for Transesophageal Echocardiography and Subsequent Treatment with Extracorporeal Cardiopulmonary Resuscitation
Topical Lidocaine and Cosmetic Procedure Risks
Not all lidocaine toxicity happens in operating rooms or emergency departments. A significant and underappreciated source of risk involves over-the-counter or compounded topical lidocaine creams applied before cosmetic procedures like laser hair removal, laser skin resurfacing, and tattooing.
The problem typically stems from applying high concentrations over large body areas, often for prolonged periods under occlusive dressings that boost absorption. In one set of cases involving laser-assisted hair removal, patients used a lidocaine-prilocaine cream and exceeded both the maximum recommended dose and the maximum recommended surface area. One patient applied more than twice the suggested amount. These patients developed an unusual clinical picture: cardiac toxicity without the ECG changes seen in injection-related cases, neurological symptoms without seizures or coma, and methemoglobinemia, a condition where the blood’s ability to carry oxygen is impaired.13PubMed. Poisoning associated with inappropriate use of a eutectic mixture of lidocaine and prilocaine before laser-assisted hair removal: about 3 cases
Laser procedures introduce an additional wrinkle. Research has documented systemic toxicity from topical lidocaine used in combination with fractional laser resurfacing, where the laser deliberately creates microscopic wounds in the skin’s outer layer. The working theory is that disrupting the skin barrier allows the anesthetic to be absorbed at a much faster rate than it would through intact skin, effectively turning a topical application into something closer to a subcutaneous dose.14JAMA Dermatology. Systemic Toxicity From Topically Applied Lidocaine in Conjunction With Fractional Photothermolysis
For anyone preparing for a cosmetic procedure that involves numbing cream, the practical guidance is clear: follow the product’s instructions on maximum dose and maximum area, do not leave it on longer than directed, and be wary of compounded formulations with unusually high lidocaine concentrations that lack the safety testing of commercial products. If the procedure involves skin disruption (as laser treatments do), the absorption risk is higher, and the clinician performing the procedure should be aware of how much anesthetic was applied before they started.
Prevention Strategies in Clinical Settings
Preventing lidocaine toxicity is far preferable to treating it, and most cases are avoidable with a few basic precautions.
Weight-based dosing is the foundation. Maximum recommended doses exist for every local anesthetic and are lower in patients with liver dysfunction, in children, and in elderly patients with reduced cardiac output. Keeping a running total of all lidocaine administered across all injection sites during a single procedure prevents the kind of creeping overdose that happens when multiple providers each add “just a little more.”
Aspiration before injection, the classic technique of pulling back on the syringe plunger before pushing the drug in, has been a standard safeguard for decades. A blood flashback suggests the needle is inside a vessel, prompting repositioning before injection. However, aspiration is not foolproof. Ultrasound guidance offers a more reliable approach: using a high-frequency probe to visualize the needle tip in real time and confirm it is in the correct tissue plane rather than in a blood vessel. One study used color Doppler imaging to identify arteries and veins before needle insertion, then watched for tissue expansion during injection to confirm extravascular placement.15European Journal of Cardiovascular Medicine. Ultrasound-Assisted Prevention of Intravascular Injection during Dermatologic Anaesthesia This technology is becoming more accessible and is increasingly standard for nerve blocks, though it remains less common in routine outpatient procedures like dental work.
Incremental injection is another practical measure. Instead of injecting the full dose all at once, clinicians can administer it in small fractions with pauses between each, watching for early symptoms. If the patient reports a metallic taste or tongue numbness during a pause, the clinician can stop before the total dose reaches toxic territory.
For facilities that use lidocaine in any significant volume, keeping lipid emulsion in stock and ensuring staff know where it is and how to administer it represents a minimal investment against a rare but potentially fatal complication.
Lidocaine Versus Other Local Anesthetics
Lidocaine occupies a middle ground among local anesthetics in terms of both potency and toxicity risk. It was first synthesized in 1943 by the Swedish chemists Nils Löfgren and Bengt Lundqvist and had a novel chemical structure for its time, being an amino-amide rather than the ester-based anesthetics that preceded it.16Tetrahedron. A brief history behind the most used local anesthetics That amide structure gives it greater stability and a lower incidence of allergic reactions compared to older agents.
Among modern local anesthetics, lidocaine is considered less cardiotoxic than bupivacaine, a longer-acting agent widely used in epidurals and nerve blocks. Bupivacaine binds more tightly to cardiac sodium channels and is harder to resuscitate from in cases of overdose. This difference is one reason lipid emulsion therapy, with its “lipid sink” mechanism, was initially studied primarily in the context of bupivacaine toxicity, where the clinical need was most urgent.12PubMed Central. Lipid Emulsion for Treating Local Anesthetic Systemic Toxicity That said, lidocaine is still capable of producing fatal cardiovascular collapse, and its widespread availability in over-the-counter formulations arguably makes it a bigger source of toxicity cases by sheer volume of exposure.
Lidocaine’s intermediate duration of action (roughly 30 to 120 minutes depending on concentration and whether epinephrine is added) means it is often chosen for shorter procedures. When longer anesthesia is needed, agents like bupivacaine or ropivacaine are preferred despite their greater toxicity profiles, simply because re-dosing lidocaine multiple times to extend its effect raises its own accumulation risk. Understanding where lidocaine falls on the spectrum helps explain why clinicians sometimes choose a theoretically “more dangerous” drug: the trade-off between duration and total dose exposure is a real consideration in procedure planning.
Vasovagal Syncope and Other Mimics
Not everything that looks like lidocaine toxicity actually is. One of the most common clinical puzzles is distinguishing true LAST from a vasovagal reaction, the garden-variety fainting episode triggered by anxiety, pain, or the sight of a needle. Both can involve a sudden drop in blood pressure, loss of consciousness, and pallor. Vasovagal syncope, however, typically involves a slow heart rate without the neurological warning signs of LAST (no metallic taste, no perioral numbness, no muscle twitching), and recovery is rapid once the patient is positioned flat with legs elevated.
Allergic reactions to lidocaine are genuinely rare but do occur and can overlap with toxicity symptoms, especially when skin flushing, swelling, and low blood pressure are present. True anaphylaxis involves urticaria (hives) and airway compromise and responds to epinephrine at standard anaphylaxis doses, whereas LAST responds to lipid emulsion and carefully dosed epinephrine. Panic attacks following injection can produce hyperventilation, lightheadedness, and tingling in the extremities that superficially resemble the early neurological signs of toxicity but resolve with reassurance and controlled breathing. The distinguishing feature, again, is the presence or absence of the classic prodromal signs like circumoral numbness and metallic taste, which point toward true systemic absorption rather than a psychological response.
Getting the diagnosis right matters because the treatments diverge sharply. Giving standard-dose epinephrine for a presumed anaphylactic reaction when the patient is actually experiencing LAST could worsen cardiac instability. Conversely, waiting to see if a “vasovagal episode” resolves on its own when the patient is actually seizing from LAST wastes critical time. When there is any doubt, erring on the side of treating for LAST (securing the airway, having lipid emulsion ready) while continuing to assess is the safer approach.